<DOC>
	<DOCNO>NCT00308022</DOCNO>
	<brief_summary>This study design exam effect early management high frequency percussive ventilation ( HFPV ) patient lung injury . Patients risk Acute Respiratory Distress Syndrome ( ARDS ) enrol randomize one two group . One group manage HFPV . The second group manage conventional ventilation utilize lung protective technique . The primary endpoint study rate ventilator associate pneumonia . We hypothesize use HFPV patient risk development ARDS decrease rate ventilator associate pneumonia compare patient manage conventional ventilation .</brief_summary>
	<brief_title>Comparison Study High Frequency Percussive Ventilation With Conventional Ventilation</brief_title>
	<detailed_description>Specific Aim 1 : This prospective randomize trial enroll 180 patient ALI/ARDS forty-eight month period . One cohort receive conventional mechanical ventilation adhere well define protocol protective lung strategy . A second cohort strategy apply utilizing VDR/HFPV . Out come measure include ; ICU/Hospital length stay , pulmonary infectious complication , airway pressure related complication , PaO2/PaCO2 level , hemodynamic profile , ventilator day . We hypothesize patient Acute Lung Injury ( ALI ) and/or Acute Respiratory Distress Syndrome ( ARDS ) manage primarily HFPV few ventilator day , few infectious complication , short ICU/hospital length stay patient manage conventional mechanical ventilation technique , maintain similar oxygenation ( PaO2 ) , ventilation ( PaCO2 ) , metabolic ( pH ) , hemodynamic ( cardiac output ) parameter . ARDS ALI show cause elevation circulate inflammatory mediator well local ( alveolar ) mediator . The presence increase amount circulate alveolar cytokine ( inflammatory mediator ) associate increased mortality patient ARDS/ALI . The pulmonary capillary bed rich source inflammatory cytokine effect ventilator strategy circulate compartmentalize ( alveolar ) cytokine level may affect outcome . Specific Aim 2 : Circulating alveolar inflammatory mediator ( IL-6 , IL-1-beta , IL-10 , TNF-alpha ) measure , activation marker increase synthesis inflammatory mediator ( NF-kappa B p38 map kinase ) determine isolated peripheral blood alveolar leukocyte . We hypothesize patient ALI/ARDS manage HFPV low level circulate alveolar pro-inflammatory cytokine ( IL-6 , IL-1-betaï€¬ TNF-alpha ) well less activation NF-kappa B p38 MAP kinase peripheral blood alveolar leukocytes..</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<criteria>PaO2/FiO2 &lt; 300 less 24 hour ( Ratio Partial pressure oxygen Fraction inspire oxygen ) Documented Pneumonia , Documented Congestive Heart Failure , Immunosuppression , Enrolled interventional trial ,</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>Acute Lung Injury</keyword>
	<keyword>Acute Respiratory Distress Syndrome</keyword>
	<keyword>High Frequency Percussive Ventilation</keyword>
	<keyword>Ventilator Associated Pneumonia</keyword>
</DOC>